359 related articles for article (PubMed ID: 29334683)
1. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
3. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.
Alvarez MC; Santos JC; Maniezzo N; Ladeira MS; da Silva AL; Scaletsky IC; Pedrazzoli J; Ribeiro ML
World J Gastroenterol; 2013 May; 19(20):3043-51. PubMed ID: 23716983
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis.
Harada H; Nie Y; Araki I; Soeno T; Chuman M; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
PLoS One; 2021; 16(12):e0260303. PubMed ID: 34936649
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment.
Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A
Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570
[TBL] [Abstract][Full Text] [Related]
6. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability].
Li JH; Shi XZ; Liu M; Wang Y; Yu ZH; Xu GW; Lu S
Ai Zheng; 2005 Mar; 24(3):273-7. PubMed ID: 15757526
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
[TBL] [Abstract][Full Text] [Related]
8. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation.
Kim KJ; Lee TH; Cho NY; Yang HK; Kim WH; Kang GH
Hum Pathol; 2013 Jun; 44(6):1055-64. PubMed ID: 23266441
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
11.
Yu X; Cao F; Yu Y; Li Y; Zhang J; Xu T; Di Q; Wu G; Zhang Z; Wang R; Li Y
DNA Cell Biol; 2021 Oct; 40(10):1251-1260. PubMed ID: 34491823
[TBL] [Abstract][Full Text] [Related]
12. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes.
Wu MS; Lee CW; Shun CT; Wang HP; Lee WJ; Chang MC; Sheu JC; Lin JT
Genes Chromosomes Cancer; 2000 Apr; 27(4):403-11. PubMed ID: 10719371
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
[TBL] [Abstract][Full Text] [Related]
15. Stage IV early gastric cancer: two cases with microsatellite instability.
An JY; Choi MG; Noh JH; Kim KM; Kim DS; Sohn TS; Kim S
Langenbecks Arch Surg; 2008 Jan; 393(1):105-9. PubMed ID: 17917741
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
[TBL] [Abstract][Full Text] [Related]
17. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
18. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
19. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.
Lee JH; Park SJ; Abraham SC; Seo JS; Nam JH; Choi C; Juhng SW; Rashid A; Hamilton SR; Wu TT
Oncogene; 2004 Jun; 23(26):4646-54. PubMed ID: 15064707
[TBL] [Abstract][Full Text] [Related]
20. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
